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LIABILITY FOR BLOOD TRANSFUSION INJURIES
INTRODUCTION
The development of the modem blood transfusion in the past
half century' is recognized by the medical profession as one of its
finest achievements. Without today's blood transfusion many of
the modem surgical practices would not be possible, and hemorrhage
would be a far greater cause of death.'
Although the transfusion of blood or pooled blood plasma is
now a routine therapeutic procedure, injuries may still result. This
Note is designed to (1) describe the two major types of transfusion
injuries, that is, reaction due to transfusion of incompatible blood,
and transmission of disease through a blood or plasma transfusion;
and (2) discuss the legal liability for these injuries of those persons
matiufacturing or supplying the blood or plasma as well as those
persons administering the transfusion.
I. TRANSFUSION OF INCOMPATIBLE BLOOD
A. Blood and Blood Groups
While almost everyone knows the general attributes of blood,
few people know of blood's detailed constituency or bodily function.
Blakiston's Medical Dictionary describes blood as:
The fluid tissue which circulates through the heart, arteries,
capillaries, and veins, ! supplies oxygen and food to the other
tissues of the body, and removes from them carbon dioxide and
waste products of metabolism. It is made up of plasma and
cellular elements. The latter consists of erythrocytes [red blood
cells], leukocytes [white blood cells], and blood platelets.3
Plasma of the blood from which fibrinogen 4 has been removed is
called serum.5
The red cells of the blood contains antigens ;6 the serum of the
1. Prior to the turn of this century, little was known about blood groups
or proper transfusion procedures. See Gradwohl, Legal Medicine 524 (1954)
(hereinafter cited as Gradwohl) ; Kabat, Blood Group Substances 2 (1956)
(hereinafter cited as Kabat).
2. See Davidsohn, Indications and Contraindications for Whole Blood
and Its Various Fractions, 24 Am. J. Clin. Path. 349 (1954) ; Wiener, Grant,
Unger, and Workman, Medicolegal Aspects of Blood Transfusions, 151
A.M.A.J. 1435 (1953).
3. Blakiston, Medical Dictionary 165 (2d ed. 1956) (hereinafter cited
as Blakiston).
4. Fibrinogen is a soluble protein in the blood plasma, which by the
action of thrombin is converted into fibrin, thus producing dotting of the blood.
Dorland, Medical Dictionary 551 (21st ed. 1948) (hereinafter cited as Dor-
land).
5. See Dorland 1132.
6. An antigen is any substance which stimulates the production of anti-
bodies or reacts with them. Blakiston 88.
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blood contains antibodies.7 Several antigens may commonly group
together in red blood cells; one such specific group of antigens con-
tained in blood is called an agglutinogen." Similarly, specific anti-
bodies may occur together in serums; one such group of antibodies
found in the serum of the blood is called an agglutinin.9 In 1900,
Karl Landsteiner discovered two distinct agglutinogens and that all
human blood contain one, both or neither of these agglutinogens in
the red blood cells. He labeled the agglutinogens as A and B. Land-
steiner also discovered that a person having one agglutinogen always
has the reciprocal agglutinin.'0 Thus, an individual having the
agglutinogen A in his red blood cells has the agglutinin anti-B in his
serum; and an individual with the agglutinogen B in his red blood
cells has the agglutinin anti-A in his serum. An individual classified
as group 0 has neither the agglutinogen A nor B, but has both the
agglutinins anti-A and anti-B. The group AB was recognized later
by Decastello and Sturli.1" The blood of an individual of group AB
possesses the opposite of group 0, that is, both the agglutinogens
A and B in the red blood cells, but neither the agglutinin anti-A nor
anti-B in his serum.
The problem of blood incompatibility arises, in essence, when a
particular agglutinogen is combined with the improper agglutinin.
For example, if blood containing the agglutinogen A is mixed with
blood containing the agglutinin anti-A, the process of agglutination,
or clumping, of the red blood cells would occur. This process often
causes serious reaction.
The blood factor, or agglutinogen,12 Rh is also of extreme im-
portance. Landsteiner and Wiener in 193713 discovered that the red
blood cells of approximately 85 per cent of the population contained
7. An antibody is a substance, either natural or induced by exposure to
an antigen, which has the capacity to react as agglutinins, lysins, precepitins,
etc., with the specific or related antigens. Blakiston 87.
8. An agglutinogen is an antigen which stimulates the formation of a
specific agglutinin. This, in turn, has the capacity to agglutinate the antigen.
Blakiston 36.
9. An agglutinin is an antibody in the serum which, when added to a
suspension of its homologous, particulate antigen, causes the antigen elements
to adhere to one another, forming clumps. Blaldston 36.
10. See Gradwohl 525; Harley, Medico-Legal Blood Group Determina-
tion 1 (1943).
11. See Gradwohl 525; Kabat 3.
12. An agglutinogen is not technically the same as a blood factor. See
Wiener, The Rh-Hr Blood Types,'2 J. For. Med. 224, 226 (1955) ; Wiener,
Owen, Stormont, and Wexler, Medicolegal Applications of Blood Grouping
Tests, 3 J. For. Med. 98, 99 (1956). For purposes of this Note, however, the
terms will be used interchangeably.
13. See Gradwohl 527; Unger, Rh-Hr Factors and Their Specific Anti-
bodies as Applied to Blood Transfusion, 24 Am. J. Clin. Path. 275 (1954).
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an element that reacted to an antibody created in the serum of
rabbits injected with blood from a rhesus monkey. An individual
whose blood would react to this serum (called anti-Rh serum)
would possess the agglutinogen Rh in his red blood cells, and was
said to be Rh positive. An individual whose red blood cells were
not agglutinated by anti-Rh serum was said to be Rh negative, that
is, lacking the Rh factor. This discovery led to the abolition of the
greatest source of post-transfusion injury since Landsteiner illus-
trated the A-B-O relationships. 4 The original Rh agglutinogen
was later labeled Rho (or D).
It is well established that there are subgroups in both the
A-B-O system and the Rh system.15 It was recognized that not all
red blood cells of group A individuals, when tested with an anti-
A serum, were equally strongly agglutinated. Those A red blood
cells that agglutinated most strongly were called A1, and those
agglutinating less strongly were called A2 . A still weaker and rarer
variety of A was labeled A3 ; and an extremely weak agglutinating
variety of A was called A4.'6 The subgroups of A'7 may be of
importance in determining the AB group (where the individual has
both the A and B agglutinogens). The AB group can be tested and
typed as either A1B or as A2B. Because the subgroup A2 aggluti-
nates weakly to the anti-A serum, the A2 agglutinogen in an A2B
individual might be overlooked and the blood incorrectly typed as B.
This A2B blood may cause a transfusion reaction if given to a re-
cipient of pure B group.
Several subgroups of the Rh agglutinogen are also now well
established. Most human red blood cells are strongly agglutinated by
the anti-Rh (or anti-D) serum, and are thus considered Rh posi-
tive. It has been shown, however, that the remainder of human red
blood cells are not necessarily Rh negative. Two other Rh factors
which may be present are rh' (or C) and rh" (or E). s These are
identified by tests with anti-rh' (C) and anti-rh" (E) serum re-
spectively. Both of these serums are now available commercially.'0
In addition, there is an Rh. variant, termed Rh. (or DO), that must
14. See Unger, supra note 13, at 288.
15. See 3 Gray, Attorneys' Textbook of Medicine 1 304.03 (3d ed. 1951)(hereinafter cited as Gray) ; Harley, supra note 10, at 6-7; Kabat 11-12.
16. Discovered when group A red blood cells were tested with an anti-A
serum obtained from group 0 blood. See Kabat 7.
17. No subgroups of the agglutinogen B have as yet been found. See
Harley, supra note 10, at 7.
18. See 3 Gray 304.03. There is another Rh factor, labeled rhw. See
Wiener, Owen, Stormont, and Wexler, supra note 12, at 99.
19. See 3 Gray 1 304.11, at 3242.
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also be tested for before an individual's blood can be identified as
Rh negative.
2 0
It has been recognized that persons who are Rh negative
possess related factors, or agglutinogens, called Hr factors. These
factors are genetically related to the three Rh agglutinogens, but the
Rh-Hr factors, although related, behave as distinct agglutinogens. 2'
Three subgroups of the Hr factor are known and labeled, similar to
the Rh system: Hr. (or d), hr' (or c), and hr" (or e). These agglu-
tinogens are tested for by the use of the serums anti-Hr., anti-hr',
and anti-hr". -2 2 Injuries due to the incompatibility of the Hr factor
are possible, and may result in the same manner as injuries due to
Rh incompatibility.2 3
Another blood grouping system, independent of all others, is
the M-N system. By injecting human red blood cells into rabbits,
Landsteiner and Levine in 1927 were able to obtain two new anti-
serums, each containing certain antibodies that would agglutinate
the red blood cells of many humans-totally independent of that in-
dividual's A-B-O type. Landsteiner and Levine called the two new
agglutinogens demonstrated by these anti-serums M and N, and
the new agglutinins anti-M and anti-N.24 If both the agglutinogens
M and N are present in the individual's red blood cells he is said to
possess the agglutinogen MN. No case has been found of an indi-
vidual lacking both of these agglutinogens. 2  Related agglutinogens
labeled S and s have also been recognized . 2 These agglutinogens are
seldom tested for prior to transfusions for they rarely cause transfu-
sion reaction. 27
20. Davenport, Transfusion Reactions and Their Treatment, 24 Am. J.
Clin. Path. 331, 336 (1954) ; Unger, supra note 13, at 288.
21. See 3 Gray 1 30425. The Rh-Hr factors are said to be allelomorph
(or allele). That is, if a particular Rh factor, rh' (C) for example, is not
found in the red blood cells, the corresponding Hr factor, hr' (c), would be
found in that person's cells. See Gradwohl 547-48.
22. Anti-serums for testing the Hr factor and its subgroups, unfortu-
nately, are difficult to obtain. 3 Gray ff 304.25, at 3264-65. In fact, anti-Hr.
serum is almost impossible to procure. Interview with Dr. Newe!l R. Ziegler,
Director, University of Minnesota Hospital Blood Bank, Minneapolis, Minne-
sota, November, 1957.
23. Another blood factor related to the Rh-Hr system has been recog-
nized-the f factor. See Kabat 13. Very recently another factor was recog-
nized-the G factor. Reported at the Annual Am. Ass'n of Blood Banks,
Chicago, Illinois, 1957.
24. See Gradwohl 525; Harley, supra note 10, at 20-25.
25. See Gradwohl 526.
26. See Gradwohl 526-27. Since finding S, the M-N system has generally
been referred to as the M-N-S system.
27. These M-N-S factors rarely cause reaction because they are of such
a low titer. "Titer" is the amount of one substance which corresponds to, re-
acts with, or is otherwise equivalent to a stated quantity of another substance.
Blakiston 1248. In this regard, it is the amount of antibodies in the serum.
In addition, these factors can be detected by careful cross-matching tests.
MINNESOTA LAW REVIEW
There are several other established blood factors or blood group
systems, all of which have been implicated as causes of transfusion
reaction.2 Among these factors are K and k (Kell-Cellano factors),
Fya (Dulfy factor), Lea (Lewis factor), Jkl (Kidd factor), Lu
(Lutheran factor), P and Tja, and U."8 The corresponding agglu-
tinins of these agglutinogens are uncommon but when they do
develop they cause a reaction when blood containing the incompati-
ble agglutinogen of one of these types is transfused to the sensitized 30
person. Transfusion reaction due to one of these factors generally
occurs upon the second or third transfusion, or a transfusion follow-
ing a pregnancy. The K (Kell) factor is believed to be one of the
more dangerous of these agglutinogens but it is still not considered
as important as the Rh factors.-'
B. Pooled Blood Plasma
Transfusions of pooled human blood plasma may be used as an
alternative to whole blood transfusions. 32 Plasma may be defined as:
The fluid portion of the blood in which the corpuscles [red and
white blood cells] are suspended. Plasma is to be distinguished
from serum which is plasma from which its fibrinogen has been
separated in the process of clotting.33
Pooled blood plasma, or normal human plasma, is defined as:
The sterile plasma obtained by pooling approximately equal
amounts of the liquid portion of citrated whole blood from eight
or more healthy humans .... Plasma is capable of serving all
the purposes for which whole blood is employed, except resto-
See Wiener, Grant, Unger, and Workman, upra note 2, at 1437. The M-N-S
system may be important in paternity determinations. See Britt, Blood
Grouping Tests and the Law: The Problem of "Cultural Lag," 21 Minn. L.
Rev. 671, 677-79 (1937) ; Wiener, Owen, Stormont, and Wexler, supra note
12, at 106; Ross, The Value of Blood Tests as Evidence in Paternity Cases,
71 Harv. L. Rev. 466 (1958).
28. New factors in blood are still being discovered. In fact, Karl Land-
steiner is reported to have predicted that blood will eventually be found to
contain so many factors that a blood type will be as distinctive as a finger-
print. See Harley, supra note 10, at 25; Unger, supra note 13, at 275.
29. See Kabat 9, 13-19; Levine, Robinson, Stroup, McGee, and Bushnell,
A Summary of Atypical Antibodies, Rare Genotypes, and ABO Heinolytic
Disease Encountered in a One Year Survey, 11 Blood 1097 (1956) ; Otten-
sooser, Mellone, and Biancalana, Fatal Transfusion Reaction Due to the Kell
Factor, 8 Blood 1029 (1953); Wiener, Owen, Stormont, and Wexler, supra
note 12, at 110-11; Wiener, Unger, and Gordon, Fatal Hemolytic Transfusion
Reaction Caused by Sensitization to a New Blood Factor U, 153 A.M.A.J.
1444 (1953).
30. See discussion pp. 646-47 infra.
31. See Ottensooser, Mellone, and Biancalana, supra note 29, at 1031.
32. Transfusions of pooled human blood have been in use only a com-





ration of the hemoglobin, and has the advantages that human
plasmas are rarely incompatible with each other and that it can
be stored for long periods of time.3
4
The plasma of human blood contains only small amounts of
agglutinogens derived from broken up red cells. When the plasma
is "pooled" the divergent agglutinins are diluted and inhibited by
union with the small quantity of dissolved agglutinogens 35 so that
pooled blood plasma can safely be administered to recipients of any
group.38 This makes plasma especially valuable in times of war or
domestic disaster. However, transfusions of pooled blood plasma
may be much more dangerous than whole blood, particularly in
respect to the transmission of homologous serum hepatitis.3r
C. Specific Injuries
Hemolysis
The most apparent indication of a transfusion of incompatible
blood is henmolysis. Hemolysis, or a hemolytic reaction, is the de-
struction of red blood cells and the resultant escape of hemoglobin.3 8
The red blood cells of the incoming blood are destroyed by aggluti-
nation; that is, they clump together when they are mixed with the
foreign agglutinins of the recipient's serum.39 When the red blood
cells of the donor clump together in the recipient's system they are
destroyed.40 The hemolysis itself is not harmful but it is an indica-
tion of the damage to other tissues of the recipient. The most serious
of these is the damage to the kidney tissues.4 1 The damage to the
kidney tissues causes anuria. Anuria is the arrest of urinary out-
put.4- When the recipient is unable to release his own waste prod-
ucts death results. Even in the absence of anuria there may be some
damage done to the recipient's kidneys.
Fortunately, the great majority of blood transfusion reactions
34. Blakiston 923.
35. See Wiener, Grant, Unger, and Workman, supra note 2, at 1438.
36. For a discussion on the preparation of blood plasma, see Hartman,
LoGrippo, and Kelly, Preparation and Sterilization of Blood Plasma, 24 Am.
J. Clin. Path. 339 (1954).
37. See discussion pp. 654-57 infra.
38. Blakiston 538.
39. A hemolytic reaction may result, although it rarely does, in the
reverse manner, by the destruction of the recipient's red blood cells by the
agglutination caused by the incompatible agglutinins of the incoming serum
of the donor. See Davenport, supra note 20, at 335.
40. See Davenport, supra note 20, at 335; Kabat 4.
41. Interview with Dr. R. W. Koucky, Medical Executive, Minneapolis
War Memorial Blood Bank, Pathologist, Fairview Hospital, Minneapolis,
Minnesota, November, 1957.
42. See Blakiston 93; Kabat 4. Anuria, however, may be caused by an
agglutination not serious enough to amount to hemolysis. Interview with Dr.
Newell R. Ziegler, supra note 22.
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are not severe; in fact, some transfusions of incompatible blood may
cause no reaction whatsoever. This is due to the low titer 3 of the
agglutinins in the recipient's serum. The few agglutinins that there
are may be used up in the reaction with the foreign agglutinogens in
the red blood cells of the incoming blood from the donor and none
are left over to damage the kidney. However, such a seemingly
uneventful transfusion may have caused the titer level of the
recipient's blood to rise sharply, and if a second transfusion of in-
compatible blood were later administered, a severe hemolytic re-
action could ensue..44
Sensitization
Transfusion injuries due to incompatibility of the Rh factor
occur in a similar manner. However, hemolysis does not result from
the first transfusion of Rh positive blood into an Rh negative re-
cipient, for human blood does not naturally contain the anti-Rh
antibodies necessary to cause agglutination. These anti-Rh agglu-
tinins may be caused to form when Rh positive agglutinogens are
first transfused into an Rh negative recipient. The recipient is then
said to be Rh sensitized.45 Upon a second transfusion of Rh positive
blood46 into the now sensitized recipient, severe hemolytic reaction
and death could result.
47
Of extreme importance is that sensitization to the Rh factor
may also result from pregnancy. During the pregnancy of an Rh
negative woman with an Rh positive fetus (the father would have
to be Rh positive), a few Rh positive agglutinogens of the fetus
may escape from the fetus to the mother and may cause the mother
to develop anti-Rh agglutinins in her serum. The first transfusion
of Rh positive blood to such a sensitized woman could cause a hemo-
lytic reaction.4 s If the mother has been Rh sensitized, either by a
43. See note 27 supra.
44. See Wiener, Grant, Linger, and Workman, supra note 2, at 1435.
45. An individual may become sensitized to five of the six Rh-Hr factors:
Rh. (D), rh' (C), rh" (E), hr' (c), hr" (e), but not to Hr. (d). Interview
with Dr. R. W. Koucky, supra note 41; 3 Gray ff 304.14; Unger, supra note
13, at 288-89. There are a few Rh negative individuals who, after being Rh
sensitized, possess an "Rh blocking antibody" which prevents the sensitiza-
tion from being exhibited. See 3 Gray 1 304.09.
46. There is almost no danger in transfusing an Rh positive individual
with Rh negative (as to all Rh factors) blood. See Wiener, Grant, Unger, and
Workman, supra note 2, at 1437. In emergencies, the hospitals use Group
O-Rh negative blood and almost never have a reaction. Interview with Dr.
R. W. Koucky, .mipra note 41.
47. See 3 Gray 1 304.14.
48. See 3 Gray 11 304.16; Wiener, Grant, Unger, and Workman, supra
note 2, at 1436.
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previous transfusion or by a previous pregnancy, the developed
anti-Rh agglutinins in her serum will affect the red blood cells of
the fetus, causing a destruction of the red blood cells of that fetus.
This is termed erythroblastosis fetalis, and is fatal to the fetus in
approximately 50 per cent of the cases in which it occurs.49
D. Legal Liability
Although there are very few reported legal actions arising out
of death or injury due to blood transfusions, it is agreed by medical
men that injury from such a cause is not uncommon."0
Mistyping and failure to type
The problem of incorrectly testing for the Rh. factor with the
resultant death of a fetus by erythroblastosis fetalis arose recently
in Berg v. New York Soc'y for the Ruptured and Crippled.51 The
hospital's technician had unexplainedly mistyped the female patient's
blood group as A-Rho positive; she was in fact group A-Rh0 nega-
tive. She was given two transfusions of Rh. positive blood. Upon a
subsequent pregnancy, the fetus being Rb positive,5 2 the anti-Rh
agglutinins in the sensitized woman's serum caused erythroblastosis
fetalis in the child. Relying on the doctrine of respondeat superior,
the woman sued the hospital for the negligence of the technician.
Before reviewing the lower court's finding of negligence, the
New York Court of Appeals was faced with what has been termed
the "medical-administrative" issue. The New York courts had for
years applied the rule that a hospital is liable for the negligent acts
of its employees only if the act was "administrative"; but if the
act could be classified as "medical," the hospital would be immune
from liability. 3 This rule had produced ridiculous technical dis-
49. See 3 Gray 304.16-.24.
50. Most transfusion reactions are very mild, and the more serious re-
action injuries are generally settled out of court. See Leading Article, Blood
Transfusions-Aedicolegal Responsibilities, 163 A.M.A.,J. 283 (1957)
Wiener, Grant, Unger, and Workman, supra note 2, at 1435.
51. 1 N.Y.2d 499, 136 N.E.2d 523 (1956).
52. The plaintiff's husband was "heterozygous"; that is, his blood con-
tained both Rh positive and Rh negative factors. A "homozygous" individual
is one who is either purely Rh positive or purely Rh negative. See 3 Gray
ff 304.04.
53. This doctrine originated by way of dictum in Schloendorff v. Soc'y of
New York Hospital, 211 N.Y. 125, 105 N.E. 92 (1914). The rule had been
strictly adhered to by the New York courts. E.g., Cadicamo v. Long Island
College Hospital, 308 N.Y. 196, 124 N.E.2d 279 (1954) ; Necolayff v. Genesee
Hospital, 270 App. Div. 648, 61 N.Y.S2d 832 (4th Dep't 1946), aff'd, 296
N.Y. 936, 73 N.E.2d 117 (1947) ; Steinert v. Brunswick Home, Inc., 259 App.
Div. 1018, 20 N.Y.S.2d 459 (2d Dep't 1940).
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tinctions, 4 and has been condemned by legal writers.5 5 The Court
of Appeals, in reversing the lower court, made a new inroad on the
rule. The court held that the technician's act was "medical," but
since the technician was not a "professional" person, the hospital
should be responsible for her negligent act. Recently, however, the
same court completely abolished the medical-administrative rule,"
stating that hospitals should bear the same burden as everyone else
under ordinary rules of respondeat superior; that is, if the person
committing the negligent act was its employee, and was acting
within the scope of his employment, the hospital should be liable.
Minnesota has adopted the medical-administrative test for the
liability of hospitals.5 8 The Minnesota court, however, has not yet
become embroiled in the seemingly nonsensical distinctions drawn
by the New York courts' application of the rule. While a court's
handling of this rule may exempt hospitals from liability for certain
acts of its employees, by categorizing those acts as "medical," the
result may be to place liability on the physicians and surgeons under
whose control "medical" acts are normally performed.59 By this
labeling process courts never squarely face the factual question of
control. Therefore, it would seem wise for the Minnesota court to
abandon the medical-administrative rule and adopt, as New York
has, the ordinary rule of respondeat superior which does place
the emphasis on the element of control.
The second issue in the Berg case was the determination of
54. Compare Cadicamo v. Long Island College Hospital, 308 N.Y. 196,
124 N.E.2d 279 (1954), with Wisner v. Syracuse Memorial Hospital, 274 App.
Div. 1087, 86 N.Y.S.2d 150 (4th Dep't 1949). Compare Sutherland v. New
York Polyclinic Hospital, 273 App. Div. 29, 75 N.Y.S.2d 135 (1st Dep't 1947),
with Iacono v. New York Polyclinic Hospital, 269 App. Div. 955, 58 N.Y.S.2d
244 (2d Dep't 1945), affd, 296 N.Y. 502, 68 N.E.2d 450 (1946). See also
Ranelli v. Soc'y of New York Hospital, 295 N.Y. 850, 67 N.E.2d (1946) ;
Grace v. Manhattan Eye, Ear and Throat Hospital, 301 N.Y. 660, 93 N.E.2d
926 (1950); 42 Cornell L. Q. 411, 413-14 (1957).
55. See, e.g., Bobb6, Tort Liability of Hospitals in New York, 37 Cor-
nell L. Q. 419, 437-38 (1952) ; 42 Cornell L. Q. 411 (1957) ; 30 St. John's L.
Rev. 297 (1956). See also Leading Article, Blood Transfusions-Medicolegal
Responsibilities, 163 A.M.A.J. 283, 284-85 (1957).
56. The court said that one who s job requires only four to six weeks
training, as the technician in this case, could not be considered "professional."
1 N.Y. at 502, 136 N.E.2d at 523 (1956).
57. Bing v. Thunig, 2 N.Y.2d 656, 143 N.E.2d 3 (1957).
58. See Swigerd v. City of Ortonville, 246 Minn. 339, 345, 75 N.W.2d
217, 222 (1956), where the court said:
"We adopt the rule that a hospital is liable for the negligence of its
nurses in performing mere administrative or clerical acts, which acts,
though constituting a part of a patient's prescribed medical treatment,
do not require the application of the specialized technique or the under-
standing of a skilled physician or surgeon."
59. See, e.g., St. Paul-Mercury Indemnity Co. v. St. Joseph's Hospital,
212 Minn. 558, 4 N.W.2d 637 (1942).
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whether a failure to accurately test for the blood factor constituted
negligence. The Court of Appeals sustained the trial court's finding
that the error of incorrectly determining the plaintiff's Rh., factor
was negligent. In evaluating whether or not the court was correct
in sustaining this finding, some familiarity with testing for blood
factors is necessary. However, the discussion will not be limited to
the testing for Rh factors, nor will it be limited to testing by
hospitals.
Hospitals and blood banks do not routinely test for all the blood
factors.20 They do type both the donor's and recipient's blood for
the A-B-O system and the Rh. factor.61 Because incompatibility due
to the A-B-O system or the Rh factor is responsible for almost all
transfusion injuries, and since it is standard practice to test for these
factors, proof of failure to do so should sustain a finding of negli-
gence. In the Berg case the error was not in failure to test for the
Rh. factor; instead, the technician inaccurately tested for Rh,. Here,
liability is not as clear as in failure to test.62 Weak anti-serum, used
through no fault of the person testing, may result in inaccurate
testing. 3 However, in Berg, the error could not have been due to
weak anti-serum, and therefore negligence seems clear.0
If the donor's blood is Rh positive as to Rh. no further tests
are made; but when the blood is negative as to Rh,, there is some
difference of professional opinion as to whether further tests with
anti-rh' (C) and anti-rh" (E) serums need be made.6 5 Most au-
thorities suggest that if the blood is negative as to Rh,, tests for
60. Interview with Dr. G. Albin Matson, Director, Minneapolis War
Memorial Blood Bank, November, 1957. See Wiener, Owen, Stormont, and
Wexler, supra note 12, at 103, 106.
61. See Wiener, Grant, Unger, and Workman, supra note 2, at 1435-36;
Wolf, Preservation and Use of Blood Testing Serumns, 24 Am. J. Clin. Path.
376 (1954). The anti-Rho serum should contain an antibody to identify the
Rh. variant Du.Interview with Dr. R. W. Koucky, .rupra note 41.
62. There have been two other cases reported involving inaccuracy in
testing. In National Homeopathic Hospital v. Phillips, 181 F.2d 293 (D.C.
Cir. 1950), the hospital technician negligently reported the blood of the donor
to be compatible with that of the patient. The transfusion of incompatible blood
caused a fatal reaction to the patient. The court affirmed a judgment holding
the hospital liable for the technician's negligence. In Gile v. Kennewick Pub.
Hospital Dist., 48 Wash.2d 774, 296 P.2d 662 (1956), the technician in-
correctly typed the patient's blood, thereby causing her death. The court dis-
missed the action since the negligence action was barred by an exemption
statute for public hospital districts, and there was no breach of warranty for
there was no "sale" of blood.
63. The hospital, however, may detect weak anti-serum by use of proper
controls on serum activity. Interview with Dr. Newell R. Ziegler, supra
note 22.
64. Such defective anti-serum could result in Rho positive blood being
typed as Rh. negative, but would never result in Rh negative blood being
typed as Rh. positive.
65. See Wolf, supra note 61, at 376.
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both rh' and rh" are imperative.66 An individual can become sensi-
tized to rh' or rh" just as he may be sensitized to Rh, and equally
serious injury can result from all three factors. Due care would
appear to require that any donor's blood found negative as to Rh.
(D) should be tested with anti-rh' (C) and anti-rh" (E) serums.
Only upon a negative finding for all these tests, including the test
for the Rh0 variant Du, should a donor's blood be classified as Rh
negative. As to the recipient's blood, since it is not standard practice
to type for rh' or rh", failure to do so should not indicate lack of
due care. These factors in recipient's blood are normally exhibited
in the hospital's cross-matching tests.6
Transfusion injury may result from sensitization to two of the
three Hr factors; hr' (c) and hr" (e).168 At least one medical writer
has stated that blood transfusions cannot safely be given without
first testing for Hr incompatibility.69 However, because it is known
that a donor's blood that is negative for all the Rh factors is neces-
sarily positive for all the Hr factors,7 0 hospitals and blood banks do
not routinely test for the Hr factors. However, blood found to be
Rh positive as to Rh. (D) may be negative as to rh' (C) or rh"
(E), thereby being hr' (c) or hr" (e) positive. Thus, failure to
test for the Hr factors, even when the blood is typed Rh positive be-
cause found to be positive as to Rh. (D), may cause a reaction to an
Hr sensitized recipient when the incompatible Hr positive blood is
transfused. Failure to test donor's blood for the Hr factors, never-
theless, would not appear to indicate a failure to exercise due care,
for the anti-Hr serums are very difficult to obtain,71 the danger of
sensitization is small,72 and lastly, the Hr factors are readily ex-
hibited by proper cross-matching tests.7 3 In view of this reliance on
66. See Unger, vtpra note 13, at 288-89; Wiener, Grant, Unger, and
Workman, supra note 2, at 1436.
67. In the major cross-matching test the recipient's serum is mixed with
the donor's cells; in the minor cross-matching test the donor's serum is mixed
with the recipient's cell. If. agglutination does not occur in either test the
bloods are said to be compatible. Blakiston 295. There are a number of cross-
matching tests; for example, the albumin test, the saline test, the high
protein test, and the anti-globulin (Coombs') test. See Wiener, Nappi, and
Gordon, Studies it Rh Sensitization, 8 Blood 1024, 1025-27 (1953). A new and
highly sensitive cross-matching test, but which is still in the trial stages, is
the papainizing test. Interview with Dr. R. W. Koucky, supra note 41.
68. Interview with Dr. R. W. Koucky, supra note 41.
69. See 3 Gray 1 304.25. Some hospitals do routinely test for hr' (c).
E.g., University of Minnesota Hospital, Minneapolis, Minnesota. Interview
with Dr. Newell R. Ziegler, Director.
70. See note 21 supra.
71. See note 22 supra.




cross-matching tests, a failure to use a cross-matching test that
demonstrates Hr incompatibility may indicate lack of due care.
Severe hemolytic reaction may also result from incompatibility
as to the M-N factors, the Kell factor, the Duffy factor, and others.
These factors, however, are not routinely tested for in donor's blood.
Reaction due to incompatibility of one of these new factors (by the
process of sensitization) is a very rare occurrence. 74 To require that
hospitals and blood banks test donor's blood for each and every one
of these newer and less common factors would create an overwhelm-
ing burden upon them. This would be particularly unreasonable in
view of the fact that the hospital's cross-matching tests will almost
always detect such an incompatibility.75 Furthermore, since it is
the judgment of almost all medical authorities concerned with
blood that tests for the M-N factors, the Kell factor, the Duffy
factor, and other new factors should not be made a part of the
routine tests for the typing of a donor's blood, courts should not
sustain findings of negligence based on a failure to tests for these
factors. Because of this reliance on the cross-matching tests, how-
ever, failure to use all the proper cross-matching tests might be a
proper basis for a negligence action.76
Mislabeling
In Mississippi Baptist Hospital v. Holmes7 7 the hospital tech-
nician mixed up the decedent's blood sample with the blood sample
of another patient on the same floor. Thereupon, he accurately typed
both samples but mislabeled each sample as a result of his original
error. Because of this mislabeling, the decedent, while undergoing
surgery, was transfused with incompatible blood and died.78 The
Supreme Court of Mississippi, while overruling that state's charita-
ble immunity doctrine, 7 held the hospital liable in damages for the
negligence of its technician.
74. See Wiener, Grant, Unger, and Workman, supra note 2, at 1437.
75. Ibid. See note 67 supra.
76. The University of Minnesota Hospital's Blood Bank has adopted
this preventive technique. They use elaborate and comprehensive cross-match-
ing tests prior to every transfusion. Interview with Dr. Newell R. Ziegler,
Director.
77. 214 Miss. 906, 55 So2d 142 (1951).
78. The court did not state what the particular incompatibility was. The
death certificate, however, showed that death was due to "acute hemolytic
anemia, due to blood transfusions of wrong type." 214 Miss. at 921, 55 So.2d
at 147.
79. The change in the financial character of "charitable institutions"
and the effect of insurance (which most "charities" carry today), have caused
most courts to abandon the archaic charitable immunity doctrine. See, e.g.,
Ray v. Tucson Medical Center, 72 Ariz. 22, 230 P.2d 220 (1951) ; Wheat v.
Idaho Falls Latter Day Saints Hospital, 78 Idaho 60, 297 P.2d 1041 (1956) ;
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Apparently almost all legal scholars and experienced medical
men would agree that a hospital's or blood bank's error in labeling a
bottle of blood should constitute sufficient facts for a court to sustain
a finding of negligence. s0
Administration of blood transfusions
Another type of error arose in Necolayff v. Genesee Hospital.8
A nurse and an interne administered a blood transfusion to the
patient notwithstanding her protests. This blood was, in fact, in-
tended for another patient, and as a result the plaintiff suffered
headaches, chills, high temperatures, and later was hospitalized at
the state mental hospital for a period of time. Although the court's
opinion makes no reference to such fact, the injury apparently was
caused by the incompatibility of her blood to that of the transfused
blood. The New York court, although still laboring under the
medical-administrative dichotomy, Held the hospital liable, reasoning
that since this negligent act was in the nature of an assault or a
trespass it could not have been a professional "medical" act.
8 2
There are a multitude of additional errors that, when committed,
may cause injury. For example, the serums used to type or cross-
match the blood samples may be interchanged; patients with similar
names may each be given blood intended for the other; or there may
be an error in reading the labels accurately. These errors are all
mechanical in nature, and proof of such errors, when shown to have
caused injury to a patient, should be sufficient to sustain a finding
of negligence.8 3
Res ipsa loquitur
It is possible that the doctrine of res ipsa loquitur8 4 should re-
ceive wider application in negligence actions based on injuries
caused by blood transfusions.8 5 To date, in only one case concerning
Haynes v. Presbyterian Hospital Ass'n, 241 Iowa 1269, 45 N.W.2d 151
(1950) ; Noel v. Menninger Foundation, 175 Kan. 751, 267 P.2d 934 (1954) ;
Mulliner v. Evangelischer Diakonniessenverein, 144 Minn. 392, 175 N.W. 699
(1920) ; Pierce v. Yakima Valley Memorial Hospital Ass'n, 43 Wash.2d 162,
260 P.2d 765 (1953).
80. See, e.g., Leading Article, Blood Transfusions-Medcolegal Re-
sponsibilities, 163 A.M.A.J. 283 (1957).
81. 270 App. Div. 648, 61 N.Y.S.2d 832 (4th Dep't 1946), aff'd, 296
N.Y. 936, 73 N.E.2d 117 (1947).
82. 270 App. Div. at 653, 61 N.Y.S.2d at 836.
83. Contaminated or overaged blood is also a possible cause of trans-
fusion reaction. See Griffitts, Heinolytic Transfusion Reactions, 2 J. For. Med.
78, 79 (1955) ; Konzelmann, Processing of Blood, 24 Am. J. Clin. Path. 369
(1954).
84. Res ipsa loquitur means, "the thing speaks for itself."
85. Although res ipsa loquitur has been applied in Minnesota in a
malpractice action, Jones v. Tri-State Tel. & Tel. Co., 118 Minn. 217, 136
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a blood transfusion has this doctrine been applied. In Sherman v.
Hartman" the needle injecting the blood into the patient's arm
slipped out of the vein and approximately 200 c.c.'s of blood
8 7
entered the tissues of her arm. The California court ruled that the
case should have gone to the jury under instructions of res ipsa
loquitur.
Res ipsa loquitur may be particularly useful in the area of blood
transfusion injuries since the injured patient is seldom in a position
to discover the specific cause of the injury. As to the applicability of
the doctrine, it would seem that the prerequisites for its use may
be met in many cases arising out of a blood transfusion injury.
By way of illustration, if a person with type A blood receives a
transfusion of type B blood, a fairly strong argument may be made
for the application of res ipsa loquitur. First, although expert medi-
cal testimony may be required, the plaintiff should be able to estab-
lish that type B blood is not normally given to a type A recipient in
the absence of negligence. Secondly, if the action is against the
hospital, it should be fairly easy to demonstrate that it was the
negligence of some employee of the hospital which caused the in-
jury. Even if the blood bank had mislabeled type B blood as type A,
the error should have been caught in cross-matching tests. Again, if
the donor's blood was properly labeled, the hospital's technician
probably failed to make the routine A-B-O typing tests on the
recipient's blood and failed to make proper or any cross-matching
tests. Lastly, it should not be difficult to establish that the plaintiff
was free from contributory negligence. In any blood transfusion-case
the receipient hardly has an opportunity to be negligent.
Emergency situations
An obvious exception to the entire foregoing discussion on
legal liability is that different requirements of due care must be
applied in cases of emergency. The degree of the emergency prob-
ably should determine how far from normal standards the hospital
N.W. 741 (1912), its application in such cases has generally been denied. See,
e.g., Johnson v. Arndt, 186 Minn. 253, 243 N.W. 67 (1932) ; Yates v. Gamble,
198 Minn. 7, 268 N.W. 670 (1936) ; Nelson v. Nicollet Clinic, 201 Minn. 505,
276 N.W. 801 (1937) ; Johnson v. Colp, 211 Minn. 245, 300 N.W. 791 (1941) ;
Wallstedt v. Swedish Hospital, 220 Minn. 274, 19 N.W.2d 426 (1945). For a
discussion of res ipsa loquitur in malpractice action see Comment, Res Ipsa
Loquitur and the Calculated Risk in Medical Malpractice, 30 So. Calif. L
Rev. 80 (1956).
86. 137 Cal. App. 2d 589, 290 P.2d 894 (1955).
87. Medical experts testified that it is a frequent occurrence for a
needle (injecting the blood) to come out of the vein. They stated, however,
that rarely does even 10 to 25 c.c.'s actually get into the body's tissues. Id. at
594, 290 P.2d at 897.
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or blood bank should be allowed to stray without being considered
negligent. For example, a badly injured person is brought to the
hospital in need of an immediate blood transfusion. Delay in getting
the blood might cause death. The technician hurriedly types the
patient's blood with the anti-A, the anti-B, and the anti-Rh0o serums,
and uses one of the fast but less sensitive cross-matching tests. If
this cross-matching test fails to detect some unusual incompatibility,
such as to the Kell factor, the hospital would clearly not be negli-
gent for not having pursued more sensitive'cross-matching tests.
However, even in emergencies there must be a minimum standard,
and patent errors in typing or labeling should possibly still be
proper bases for a cause of action.
II. TRANsmissioN OF DISEASE
There are several diseases that one human can transmit to an-
other through a transfusion of whole blood or pooled blood plasma.
The viruses or organisms of such diseases may be carried in the
donor's blood, and may pass with the blood to enter the blood
stream of the recipient. Three diseases which may present this prob-
lem are homologous serum hepatitis, malaria, and syphilis., 8 Of
these three, the transmission of homologous serum hepatitis occurs
most frequently and because the resultant illness is serious and
sometimes fatal, this entire problem is an important one in the field
of blood and plasma transfusions.
A. Homologous Serum Hepatitis
Hepatitis is the inflammation of the liver. Viral hepatitis is the
inflamation of the liver due to a virus infection. Homologous
serum hepatitis, or the type of hepatitis contracted by blood trans-
fusion, is defined by Blakiston as:
A form of viral hepatitis transmitted by the parenteral injection
of the human blood or blood products contaminated with the
causative agent.89
The terms "homologous serum jaundice" and "transfusion jaun-
dice" are also used to describe this type of hepatitis.
The virus of homologous serum hepatitis cannot be detected in
donors by any known medical test. Neither can the virus be detected
88. Other diseases might be transmitted through a blood or plasma
transfusion; for example: respiratory infection, brucellosis, measles, allergic
states, and influenza. See Wiener, Grant, Unger, and Workman, supra note





in the blood of the donor when taken or in pooled blood plasma. This
dilemma has been a subject of medical concern for many years 0° and
a number of persons have been injured as a result of the trans-
mission of this hidden virus. Formerly the only precaution the blood
banks and hospitals could take was to warn prospective donors of
these dangers and try to eliminate those who might have been ex-
posed to such a virus.91 For a time, the medical profession thought
a process of irradiation could kill the hepatitis virus in pooled
blood plasma. It was soon shown, however, that irradiation was
unable to completely destroy the virus.9 2 While the possibility of
transmission of homologous serum hepatitis in whole blood is quite
slim,9 3 the possibility of transmission in pooled blood plasma is
multiplied by the number of units making up the pool, for a virus
from a single donor can contaminate the entire pool of blood
plasma, rendering every transfusion from such a pool highly
dangerous.9 4
In Parker v. State9 9 the patient was given a transfusion of
pooled blood plasma which unknowingly contained the hepatitis
virus, and as a result the patient died. The decedent's administrator
brought an action for negligence against the State (as distributor
of the plasma) on the ground that the State should have warned the
physicians of the danger of the hepatitis virus. The court affirmed
a dismissal of the action on the ground that it was reasonable for
the State to expect that any authorized person using the plasma
would know of the danger. Although the physician on whose orders
the transfusion was given was not a party to the action, the court
90. See, e.g., Stokes et al, The Carrier State in Viral Hepatitis, 154
A.M.A.J. 1059 (1954) ; Wiener, Grant, Unger, and Workman, supra note 2,
at 1438.
91. Interview with Dr. G. Albin Matson, supra note 60. See Correspond-
ence, 151 A.LA.J. 763 (1953).
92. See, e.g., Albrecht et al, Serum Hepatitis Apparently Acquiredfrot Irradiated Plasma, 152 A.M.A.J. 1423 (1953) ; Murphy and Workman,
Serum Hepatitis from Pooled Irradiated Dried Plasma, 152 A.M.A.J. 1421(1953).
93. One instance of transmission of hepatitis in 200 whole blood trans-
fusions is a fair estimate. See Madsen, Incidence of Hepatitis After Use of
Blood and Serum Transfusions, 155 A.M.A.J. 1331 (1954); Wiener, Grant,
Unger, and Workman, supra note 2, at 1438.
94. Reports of transmission of hepatitis in plasma transfusions vary
considerably, from 37 up to 12% of those receiving plasma transfusions.
See Albrecht et al, supra note 92; Madsen, supra note 93; Murphy and Work-
man, supra note 92; Wiener, Grant, Unger and Workman, supra note 2, at
1438. An additional problem is that even persons who have never had
hepatitis can possess the virus and transmit it through their blood; such
persons are called "carriers." See Barnett, Fox, and Snavely, Hepatitis
Following the Use of Irradiated Human Plasma, 144 A.M.A.J. 226 (1950).
95. 280 App. Div. 157, 112 N.Y.S.2d 695 (3d Dep't 1952). ,
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indicated that he would not be considered negligent since there was
a need for a fast transfusion, approaching an emergency.
In Hidy v. State,98 the decedent had been in the hospital 15
hours prior to his operation; no blood typing tests had been made;
and there were ample supplies of whole blood available for trans-
fusion. The court again ruled that the State, as distributor of the
plasma, was not negligent. The court stated that the only way the
State could prevent this type of injury would be to recall all the
pooled blood plasma, but this is highly undesirable because pooled
blood plasma has many advantages notwithstanding its dangers. The
court, however, clearly implied that the physician might have been
negligent in making his choice to use plasma rather than whole
blood especially in the absence of an emergency.
A second basis of liability was tried in Merck & Co. v. Kidd.17
The plaintiff, injured due to transmission of homologous serum
hepatitis, argued that the sale of the plasma containing the hepatitis
virus violated the Tennessee Food, Drug and Cosmetic Act,98 thus
constituting negligence per se. That statute states that a drug is
adulterated if it consists in whole or in part of any "filthy, putrid, or
decomposed substance" and that such adulterated drugs are pro-
hibited. The plaintiff argued that the hepatitis virus in the pooled
blood plasma was a "filthy" substance making the plasma "adulter-
ated." The court, after pointing out the medical impossibility of
detecting or destroying this virus, held that the virus was not a
"filthy" substance within the "intendment" of the statute.9 9 The
lone dissenter, apparently more logic-minded than policy-minded,
argued that whether or not the virus could be detected in the plasma
was irrelevant.
A somewhat surprising aspect of the Merck case is that the
court, in 1957, stated that there was still no scientific procedure
available to detect or destroy the virus of homologous serum hepa-
titis. This, however, is not true, for it has been known for several
years that the homologous serum hepatitis virus in pooled blood
plasma can be totally destroyed by a process of storing the plasma
at room temperature for six and perhaps as few as three months.100
The Minneapolis War Memorial Blood Bank has used this storage
process and irradiation for seven years and has encountered not
96. 207 Misc. 207, 137 N.Y.S.2d 334 (N.Y. Ct. Cl. 1955), aff'd, 2 App.
Div. 2d 644, 151 N.Y.S.2d 621 (1956).
97. 242 F.2d 592 (6th Cir. 1957), cert. denied, 78 Sup. Ct. 15 (1957).
98. Tenn. Code Ann. §§ 52-103, 52-115 (1955).
99. 242 F.2d at 596.
100. Interview with Dr. G. Albin Matson, supra note 60. See Allen,
Enerson, Barron, and Sykes, Pooled Plasmna with Little or No Risk of
Homologous Seruim Jaundice, 154 A.M.A.J. 103 (1954).
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one incidence of transmission of homologous serum hepatitis.1 1
Since the virus-killing action of storage has been so widely accepted,
failure to utilize such a virus-destroying process resulting in trans-
mission of the disease might become a proper basis for a negligence
action. This process is now widely known among persons dealing
with plasma preparations and is not a burdensome, expensive or im-
practical requirement to utilize.1
0 2
Unfortunately, this virus-destroying process is not effective for
whole blood. Since medical scientists have not yet discovered a
method of detecting or destroying the virus in whole blood, and
the blood banks and hospitals must still rely on the donor's medical
history and truthfulness, it would seem that failure to prevent the
transmission of homologous serum hepatitis in whole blood trans-
fusions-if stringent donor requirements are set up-certainly is no
indication of negligence of either the blood bank or the hospital.
B. Malaria
A second disease that may be transmitted from a donor to a
recipient through a blood transfusion is malaria. Malaria may not
be transmitted through a pooled blood plasma transfusion, for the
malaria organisms reside in the cells of the blood, and plasma con-
tains no cellular components. 0 3 In whole blood, the only known
method of possibly detecting this organism is through a detailed
and extensive microscopic examination. Because of the impracti-
cality of testing each sample of blood, as well as the inconclusiveness
of the findings, blood banks are again forced to rely on the veracity
or the memory of the donor himself. Storage of whole blood for
more than five days may destroy certain types of malaria organ-
isms.10 4 Although medical journals report not infrequent cases of
transmission of malaria, 0 5 no reported legal actions based on con-
traction of this disease could be found. Liability based on the trans-
mission of malaria should be limited to instances of actual negli-
gence. In practice, liability would probably be limited to failure
to ask questions regarding malaria.
C. Syphilis
The transmission of syphilis occurred occasionally in the past
when blood was transfused immediately from donor to recipient.
101. Interview with Dr. R. W. Koucky, stpra note 41.
102. See Allen, Enerson, Barron, and Sykes, supra note 100, at 107.
103. See Wiener, Grant, Unger, and Workman, supra note 2, at 1438.
104. Ibid.
105. Ibid. See also Trumbull, Requirements of Donor, 24 Am. J. Clin.
Path. 254, 255-56 (1954).
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It was subsequently found that chilling the whole blood would
effectively destroy the syphilis agent ;106 therefore, failure to chill
the blood resulting in transmission of syphilis should, in the absence
of an emergency, constitute negligence on the part of the supplier
of that blood.
10 7
III. WARRANTY AND STRicT LIABILITY
A. Warranty
Another basis used in attempting to impose liability on suppliers
of whole blood or pooled blood plasma was attempted in Perlmutter
v. Beth David Hospital,°8 that of breach of an implied warranty.
The transfusion in this case was of whole blood. As a result of the
transfusion the plaintiff became afflicted with homologous serum
hepatitis. The plaintiff argued that since her hospital bill included a
separate item of $60 for "blood," the transaction constituted a
"sale" within the Sale of Goods Act, 09 thereby entitling her to
actions on the implied warranties of "fitness" and "merchantability."
The New York Court of Appeals, in a four-to-three decision, re-
versed a denial of the hospital's motion for a dismissal, ruling that
the administration of the blood transfusion, even though specially
itemized on her bill, was merely one incidental part of her medical
treatment, that is, medical "services." 110 The court again pointed out
the lack of means of detecting or destroying the virus, and referred
quite clearly to the undesirability of making hospitals insurers of
the products they administer."'
The effects of the Perlmutter decision, especially because of the
closely divided court, have been far-reaching. The Legal Depart-
ment of the American Medical Association has recently recom-
106. See Wiener, Grant, Unger, and Workman, supra note 2, at 1438;
Trumbull, supra note 105, at 256.
107. The only reported case based on negligent transmission of syphilis
is Giarnbozi v. Peters, 127 Conn. 380, 16 A.2d 833 (1940), a malpractice action
against a physician who failed to test the donor's blood for syphilis. The
negligence action, however, was barred by a two-year statute of limitations.
108. 308 N.Y. 100, 123 N.E.2d 792 (1954). For comments on the case
see Leading Article, Blood Transfusions-Medcolegal Responsibilities. 163
A.M.A.J. 283 285-86 (1957) ; 69 Harv. L. Rev. 391 (1955) ; 29 St. John's L.
Rev. 305 (1955) 103 U. of Pa. L. Rev. 833 (1955).
109. N.Y. Pers. Prop. Law, § 96 (identical with the Uniform Sales
Act).
110. This case was followed in Gile v. Kennewick Pub. Hospital Dist.,
48 Wash.2d 774, 296 P.2d 662 (1956).
111. "The art of healing frequently calls for a balancing of risks and
dangers to a patient. Consequently, if injury results from the course adopted,
where no negligence or fault is present, liability should not be imposed upon
the institution or agency actually seeking to save or otherwise assist the
patient." 308 N.Y. at 107, 123 N.E.2d at 795.
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mended that hospitals refrain from itemizing a specific charge for
"blood," at least to eliminate the patent resemblance of the trans-
action to a "sale. 11 . 2 The Department also suggested that hospitals
adopt a form of contract, or of consent, in which the patient would
be warned of the inherent dangers of both blood and plasma trans-
fusions, and contain a disclaimer of the warranty of fitness. 13 In
Minneapolis, however, neither of these proposals have been
adopted.1 4 The reason that specific charges for blood have not been
discontinued concerns the policies and practices of procurement of
blood for transfusions. The charge of $60 in the Perlmutter case,
and $30 charge used in Minneapolis, is not the "cost" of that
blood, and the recipient is not, strictly speaking, buying the blood.
The fee is in the nature of a deposit. If the patient arranges to have
a friend or relative donate a unit of blood, that is, replace the unit
of blood given the patient, the "charge" is refunded. The "charge" is
deliberately made high in order to provide a substantial induceinent
to replace the blood. If the blood banks and hospitals do not obtain
replacement of blood from these reliable (or non-indigent) patients
or their families, they will have to open their doors to the indigent
skid-row donor whose medical history may be extremely unreliable.
Thus, the blood banks and hospitals argue that their primary pur-
pose in using this "charge" for blood is the protection of the
community in general, and that the "charge" for the transfused
blood should not indicate a "sale" but a "service."
The Minneapolis community blood bank, the Minneapolis War
Memorial Blood Bank, formerly helped alleviate the crowded
hospital dilemma by providing a service within the bank itself of
administering blood and plasma transfusions, thereby making it
unnecessary for the recipient to occupy a hospital bed. As a result
of the close Perlmutter decision, the Blood Bank discontinued this
service for fear that such an isolated transfusion might be con-
sidered a "sale" and not an incident to medical "services."' "
Possibly an argument could be made that the blood banks that
supply the blood and plasma to the hospitals"0 should be held for
breach of warranty because the replacement "charge" is partly
shared by them if the blood is not replaced, and that this should
constitute a "sale." Assuming that the patient could prove this
112. See Leading Article, Blood Tran.sfusions-Medicolegal Responsi-
bilities, 163 A.M.A.J. 283, 286 (1957).
113. The Department provides suggested forms for both whole blood
and plasma transfusions. Id. at 286-87.
114. Interview with Dr. R. W. Koucky, supra note 41.
115. Interview with Dr. G. Albin Matson, supra note 60.
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direct relationship resembling a sale, the blood banks may contend
that they should have the same protection the hospitals have under
the Perlmutter rule. The argument is that the collection of blood from
a multitude of donors is a complicated task, and that it was recog-
nized that it was much more desirable, from a community stand-
point, to relegate this responsibility of collecting blood and making
plasma to a central agency-the community blood bank. Therefore,
the community blood bank is not an independent organization selling
blood to the many hospitals; rather it is simply executing one of the
multitudinous aspects of the hospitals' "services."
But arguments about "sale" or "service" seem to lead nowhere
in this area. The real question involved seems to be one of policy.
Furtheri the question appears to be the same whether one is con-
sidering the transfusion of "diseased" blood or "incompatible"
blood-although transfusion of "incompatible" blood may only
come under the warranty of "fitness for a particular purpose."
Basically, a court, faced with this warranty question, should
attempt to determine the impact of what would in fact amount to
strict liability on hospitals and blood banks. Since the ultimate
supplier usually bears the burden in breach of warranty cases, it
seems reasonable to suppose that the ultimate burden in "bad blood"
cases would fall on the blood banks. Other factors which should be
considered in resolving the warranty question are the same or
similar to the factors considered in the separate concept of "strict
liability," treated below.
B. Strict Liability
Liability without fault may also be obtained through a modern
device, separate from warranty, called "strict liability." This is a
social device developed in the last 100 years," 7 designed to shift
certain inevitable losses to those best able to bear them-generally
a substantial segment of society."' In the area of blood transfusions,
the doctrine of strict liability would hold the suppliers and those
administering blood transfusions absolutely liable (no negligence
need be proven) for all transfusion injuries. The hospitals, blood
116. The Minneapolis War Memorial Blood Bank supplies whole blood
and plasma to all but four Minneapolis hospitals. The exceptions are Uni-
versity of Minnesota Hospital, Veterans' Administration Hospital, General
Hospital, and Swedish Hospital. Interview with Dr. G. Albin Matson, supra
note 60.
117. The doctrine originated in England in Rylands v. Fletcher, L.R. 3
H.L. 330 (1868). The rule was early adopted in Minnesota, Cahill v. East-
man, 18 Minn. 324 (1872), and is still followed today, Bridgeman-Russell Co.
v. City of Duluth, 158 Minn. 509, 197 N.W. 971 (1924).
118. See Prosser, Torts, 317-18 (1955).
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banks, or manufacturers could then "shift" the burden of the loss
over the entire group of persons receiving transfusions. Or, by
means of insurance, shift the burden of loss upon all the hospitals
and blood banks which would in turn shift the burden upon all the
users of their facilities-a substantial segment of society.
Strict liability, however, is limited in its applicability. Prosser
states that this doctrine has normally found expression "where the
defendant's activity is unusual in the community, and the danger
which it threatens to others is unusually great even though the enter-
prise is conducted with every possible precaution.""1 9 He further
states that the "courts have tended to lay stress upon the fact that
the defendant is acting for his own purposes, and is seeking a
benefit or a profit of his own from such activities.' 1 20 Viewed in
this light, strict liability seems inapplicable to blood transfusions.
It can hardly be said that blood transfusions are unusual in the
community; on the contrary, transfusions are an everyday occur-
rence in a community of any size. Secondly, although some danger
is admittedly involved, the danger, absent negligence, can hardly
be classified as unusually great. Lastly, and possibly most important,
the supplier of blood, at least the hospital, does not seem to fit into
the category of one "acting for his own purposes." The latter cate-
gory seems to imply primarily a profit-seeking defendant. Although
some hospitals do, of course, show a profit, the tag of "primarily
profit-seeking" would appear to be a misnomer.
CONCLUSION
Although it would seem clear that doctors and hospitals should
be just as responsible for acts of negligence as other tort defendants,
the wisdom of imposing liability in the area of blood transfusions,
through use of negligence per se-under a Pure Food and Drug
Act, implied warranty, or strict liability, is oren to question. Strong
arguments, however, may be advanced on either side. This Note
has not attempted to resolve these questions, but rather to present
the opposing views-with some leaning toward not imposing
liability. Final determination of the questions raised calls for an
extensive factual inquiry into the problems discussed in the sections
of this Note on warranty and strict liability. Perhaps this inquiry
could take the form of a cooperative research project conducted by
lawyers, doctors, blood experts, and administrators of both hospitals
and blood banks.
119. Id. at 317.
120. Id. at 318.
